PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila.

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Multisite hyperphosphorylation of tau is linked to neurodegenerative disease pathogenesis, including Alzheimer's disease (AD).
• The specific phosphorylation events critical for tau toxicity and their regulatory mechanisms remain largely undefined.
• Understanding tau phosphorylation is crucial for developing effective therapeutic interventions.

Purpose of the Study:

• To elucidate the role of Drosophila PAR-1 kinase in initiating tau phosphorylation and toxicity.
• To identify the specific phosphorylation sites targeted by PAR-1 and downstream kinases.
• To differentiate the impact of various tau phosphorylation events on disease pathology.

Main Methods:

• Utilized Drosophila models to study tau phosphorylation and toxicity.
• Employed biochemical assays to determine direct phosphorylation sites by PAR-1.
• Investigated the functional consequences of mutating PAR-1 phosphorylation sites on tau.

Main Results:

• Drosophila PAR-1 kinase directly phosphorylates tau at sites S262 and S356, initiating a cascade.
• PAR-1 phosphorylation is a prerequisite for downstream kinases (GSK-3, Cdk5) to modify tau at other sites.
• Mutating PAR-1 sites significantly reduced overall tau phosphorylation and toxicity compared to downstream site mutations.

Conclusions:

• Drosophila PAR-1 acts as an initiator kinase in the tau phosphorylation pathway, driving toxicity.
• These findings distinguish the roles of different tau phosphorylation events in disease.
• PAR-1 and its targeted sites represent potential therapeutic targets for AD and related disorders.